Prescription Drug Rebate Reform Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 17, 2019)
Prescription Drug Rebate Reform Act of 2019
This bill requires private health insurance plans to set any coinsurance rate for a covered prescription drug based on the net price of the drug (the price after accounting for rebates and discounts provided by the drug manufacturer) and not the list price (the initial wholesale price set by the drug manufacturer). This requirement applies when a plan holder has an unmet deductible or other coinsurance obligation for prescription drug benefits under the plan.
The bill does not prohibit a plan from requiring a copayment provided that such copayment is not based on the cost of the drug.
What just happenedJul 18, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 17, 2019
- Jul 18, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 17, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 17, 2019IntroReferralIntro-H
Introduced in House
- Jul 17, 2019IntroReferral1000
Introduced in House